Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
58
EVBN Quote, Financials, Valuation and Earnings
Last price:
$43.55
Seasonality move
:
0.54%
Day range:
$43.98 - $44.30
52-week range:
$24.07 - $46.21
Dividend yield:
2.99%
P/E ratio:
13.28x
P/S ratio:
2.92x
P/B ratio:
1.32x
Volume:
9.8K
Avg. volume:
21.1K
1-year change:
38.98%
Market cap:
$245M
Revenue:
$94.1M
EPS (TTM):
$3.33
Analysts' Opinion
-
Consensus RatingEvans Bancorp has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Evans Bancorp has an estimated upside of 13.21% from its current price of $44.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $44.21.
Fair Value
-
According to the consensus of 0 analysts, Evans Bancorp has 13.21% upside to fair value with a price target of -- per share.
EVBN vs. S&P 500
-
Over the past 5 trading days, Evans Bancorp has underperformed the S&P 500 by -0.26% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Evans Bancorp does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evans Bancorp revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Evans Bancorp reported revenues of $18M.
Earnings Growth
-
Evans Bancorp earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Evans Bancorp reported earnings per share of $0.53.
Enterprise value:
4.9M
EV / Invested capital:
0.01x
Price / LTM sales:
2.92x
EV / EBIT:
0.06x
EV / Revenue:
0.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.69x
Price / Operating cash flow:
34.21x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.83%
Net Income Margin (TTM):
22.05%
Return On Equity:
10.61%
Return On Invested Capital:
5.39%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $92.9M | $85.3M | $83.4M | $19.8M | $18M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $4.01 | $3.72 | $3.33 | $0.66 | $0.53 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $259.4M | $445.2M | $390.3M | $359.8M | $399.3M | |
| Total Assets | $2.1B | $2.2B | $2.1B | $2.2B | $2.3B | |
| Current Liabilities | $4.4M | $4M | $9.8M | $13.4M | $8.3M | |
| Total Liabilities | $1.9B | $2B | $2B | $2B | $2.1B | |
| Total Equity | $162.9M | $178.8M | $149.9M | $150.9M | $185.8M | |
| Total Debt | $78.5M | $67.5M | $73.6M | $182.4M | $159.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $24.9M | $18.8M | $7.3M | $3.4M | $11.9M | |
| Cash From Investing | -$198.9M | -$49.7M | $35.2M | -$27.6M | -$19.1M | |
| Cash From Financing | $3.5M | $34.9M | $60.3M | $24M | $9M | |
| Free Cash Flow | $24.1M | $17.9M | $7.1M | $3.3M | $11.9M | |
EVBN
Sector
Market Cap
$245M
$698.9M
Price % of 52-Week High
95.67%
88.68%
Dividend Yield
2.99%
2.18%
Shareholder Yield
4.28%
3.87%
1-Year Price Total Return
38.98%
7.42%
Beta (5-Year)
0.922
0.734
Dividend yield:
2.99%
Annualized payout:
$1.32
Payout ratio:
39.46%
Growth streak:
10 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$44.23
200-day SMA
Buy
Level
$34.00
Bollinger Bands (100)
Buy
Level
35.78 - 43.68
Chaikin Money Flow
Sell
Level
-2.4M
20-day SMA
Sell
Level
$44.51
Relative Strength Index (RSI14)
Buy
Level
51.79
ADX Line
Buy
Level
12.12
Williams %R
Neutral
Level
-59.3472
50-day SMA
Buy
Level
$42.87
MACD (12, 26)
Buy
Level
0.30
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Sell
Level
-542.7K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4656)
Sell
CA Score
(Annual)
Level (-2.2405)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.5739)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evans Bancorp Inc is a financial holding company. Through its subsidiaries, it provides various banking services to consumers and commercial customers in the USA. The firm operates in two segments, Banking Activities and Insurance Agency Activities. The banking business segment includes both commercial and consumer banking services, including lending and depository services and offering non-deposit investment products, such as annuities and mutual funds. The insurance agency segment includes the activities of selling various premium-based insurance policies on a commission basis, including business and personal insurance, employee benefits, surety bonds, risk management, life, disability and long-term care coverage, and providing claims adjusting services to various insurance companies.
Stock Forecast FAQ
In the current month, EVBN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVBN average analyst price target in the past 3 months is --.
-
Where Will Evans Bancorp Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evans Bancorp share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Evans Bancorp?
Analysts are divided on their view about Evans Bancorp share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evans Bancorp is a Sell and believe this share price will drop from its current level to --.
-
What Is Evans Bancorp's Price Target?
The price target for Evans Bancorp over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EVBN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evans Bancorp is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of EVBN?
You can purchase shares of Evans Bancorp via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evans Bancorp shares.
-
What Is The Evans Bancorp Share Price Today?
Evans Bancorp was last trading at $43.55 per share. This represents the most recent stock quote for Evans Bancorp. Yesterday, Evans Bancorp closed at $44.21 per share.
-
How To Buy Evans Bancorp Stock Online?
In order to purchase Evans Bancorp stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
